Thyrotropin-releasing hormone (TRH, <Glu-His-Pro-NH2) was initially isolated in the hypothalamus (1, 2) ; however, its distribution is ubiquitous, including the whole brain and the gastrointestinal tract (3) . The ontogenetic pattern of TRH in the pancreas of the rat is peculiar, with the highest levels just after birth, decreasing rapidly toward low levels in the adults (4) (5) (6) . Despite the early isolation ofTRH, its biosynthesis has remained obscure until recently (7) . Results from different groups (including ours) support the hypothesis that TRH, like other neuropeptides, arises from the posttranslational processing of a large precursor protein (8, 9) . This hypothesis, strongly reinforced by the determination of the cDNA sequence of a portion of the TRH precursor in amphibian skin (10) , has been confirmed by the characterization of a cDNA clone coding for the precursor of TRH in the rat hypothalamus (11) .
TRH is a COOH-terminally a-amidated tripeptide. Amino acid sequence data for many peptide precursors (including the incomplete sequence of the TRH precursor in amphibian skin) indicate that peptides with COOH-terminal glycine are the intermediate precursors to COOH-terminally a-amidated peptides (12) . The mechanisms of the posttranslational modifications of the TRH precursor have not been established. First, they may involve proteolytic cleavages that give rise to the tetrapeptide Gln-His-Pro-Gly. Then, TRH may be generated after the spontaneous cyclization of the NH2-terminal amino acid and the enzymatic amidation of proline, with the glycine residue acting as the amide donor under the action of a peptidylglycine a-amidating monooxygenase (PAMase). The hypothetical pathway of TRH described above is supported by studies on the maturation of the prooxytocinneurophysin precursor (13, 14) . PAMase activity has been characterized in the intermediate and anterior lobes of the pituitary (15) (16) (17) , in the mouse pituitary corticotropic tumor cells (At-T20) (18) , as well as in the hypothalamus, where it may be involved in the biosynthesis of several bioactive peptides, such as TRH, oxytocin, and vasopressin (19) . PAMase activity is barely detectable in the pancreas of the adult rat (20) .
In this study, we present evidence that PAMase* activity is high in the rat pancreas during the neonatal period and follows a pattern similar to that of TRH levels in this tissue. Our results suggest also that a significant fraction of pancreatic PAMase activity is involved in the biosynthesis of TRH.
MATERIALS AND METHODS
Animals. Female Long Evans rats were bred in our laboratory and their litters were used in the experiments. The day sperm was identified in the vaginal smear was designated day 0 of pregnancy (gestational length, 22 days) and the day ofbirth was designated day 0 of life. The animals were housed in individual cages at 23 ± 2°C under controlled light (0700-2000 hr) daily and fed Purina Chow and tap water ad libitum.
Amidation Assay. Amidation activity was measured on crude mitochondrial/secretory granules prepared from freshly dissected pancreata collected from 19-day fetuses as well as from 1-to 90-day-old rats. The pancreata were homogenized at 4°C (in a Teflon/glass homogenizer, 10 strokes) in 10 vol of 0.3 M sucrose/0.02 M Tris HCl, pH 7.4. The homogenate was centrifuged at 400 x g for 10 min at 4°C to sediment nuclei and cell debris. Supernatant was then centrifuged at 12,000 x g for 30 min at 4°C. The pellet containing the mitochondrial/secretory granules was resuspended in 0.5 ml of 10 mM phosphate buffer (pH 7.0), submitted to three consecutive freeze-thaw cycles, and stored until assay for amidating activity. The protein concentrations in these preparations were determined according to Bradford (21) PAMase activity. However, since the optimal amount of CuS04 to be added in the assay appears to be critical according to the tissue (20) , all of the measurements of PAMase activity were performed with various amounts of CuS04 ranging from 10 to 180 AM. The rate of the aamidation reaction was also determined in the presence of an air atmosphere (control) or in the presence of a constant stream of helium to replace most of the molecular oxygen. The PAMase assay was performed at 370C for 4 hr in a final volume of 0.05 ml using the method of Eipper et al. (22) . The following reagents were added to each tube: 3 mM ascorbate, 100 All samples were assayed in duplicate and generally deviated <5% from the mean.
Determination of the Conversion Rate of <Glu-His-Pro-Gly into <Glu-His-Pro-NH2 (TRH) by Neonate Rat Pancreatic Preparation. As suggested in the Introduction, the tetrapeptide <Glu-His-Pro-Gly is a putative natural substrate for PAMase activity in pancreatic secretory granules. Thus, it was of interest to test whether pancreatic PAMase was able to convert <Glu-His-Pro-Gly into TRH. The tetrapeptide <Glu-His-Pro-Gly (synthesized for us by J. Van Rietschoten and C. Granier, Institut National de la Sante et de la Recherche Medicale, U 172, Marseille, France) (25 ,M) was incubated with a pancreatic mitochondrial/secretory granule preparation from 3-day-old rats under optimal assay conditions at 37°C for 0-4 hr. The reaction was stopped by the addition of 0.5 ml 5 M acetic acid, followed by boiling for 10 min. The samples then were centrifuged at +40C (2000 x g, 10 min) and the supernatant was evaporated to dryness. TRH levels in the tubes were determined by radioimmunoassay (23) .
Cellular Localization of PAMase Activity in the Rat Pancreas. To study the cellular localization of PAMase activity in the neonate rat pancreas, 1-day-old rats were injected with streptozotocin, a drug displaying specific cytotoxicity toward the beta cells of the endocrine pancreas (24) . Streptozotocin (Sigma) was dissolved extemporaneously in 0.1 M sodium citrate (pH 4.5) and injected i.p. into 1-day-old rats (150 mg/kg). Control rats received the same volume (0.1 ml) of the vehicle. At the age of 4 and 6 days, the rats were sacrificed, and their pancreata were collected and prepared for measurement of PAMase activity. In the group of streptozotocintreated rats, only the pancreata from rats with glycemia >3.50 g/liter were used for the experiment.
Subcellular Localization of PAMase Activity in the Neonate
Rat Pancreas. A pancreatic mitochondrial/secretory granule preparation was obtained as described, except that the initial homogenization was performed after exposure to DNase I (26 ,ug/ml at room temperature for 5 min). This preparation was layered on the top of 11 ml of 33.3% isoosmotic Percoll (Pharmacia, Upsala) in 0.3 M sucrose/0.02 M Tris HCl, pH 7.4 . After centrifugation at +40C (65,000 x g, 60 min), 0.4-ml fractions were collected by puncturing the tubes and were assayed for PAMase activity (22) , TRH (23) , and TRH precursor (9) .
Measurement of TRH and Its Precursor. TRH levels were determined by a radioimmunoassay (23) in subcellular fractions from 3-day-old rat pancreas and in extracts from rat pancreata obtained at different developmental stages. Pancreatic extracts were prepared as follows. Freshly dissected rat pancreata were boiled for 15 min in 10 vol of 5 M acetic acid, cooled on ice, homogenized in a Teflon/glass homogenizer (10 strokes), and centrifuged at 2500 x g (40C, 15 min).
The acidic and clear supernatant was evaporated to dryness in a Speed Vac apparatus (Savant, Hicksville, NY). The TRH antiserum shows 1% crossreaction with <Glu-His-Pro-Gly and no crossreaction (<0.01%) with the putative metabolites of TRH, <Glu-His-Pro-OH (TRH-OH), and histidylprolinediketopiperazine.
The levels of TRH precursor were determined in the subcellular fractions from 3-day-old rat pancreas as described by Ouafik et al. (9) . Briefly, the samples were appropriately diluted and subjected to a sequential enzymatic treatment by L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin (50 jig/ml) for 2 hr at 370C (Worthington) and carboxypeptidase A (Sigma) for 2 hr at 370C. The enzymes were successively heat-inactivated (950C, 20 min). The sequence TRH-OH generated by the enzymatic treatment of the precursor for TRH was measured by a specific radioimmunoassay (6) . TRH precursor levels were expressed as the difference between the values of TRH-OH-immunoreactive material measured in the different fractions after and prior to sequential enzymatic treatment. The antiserum anti-TRH-OH shows no significant crossreaction with TRH and <Glu-His-Pro-Gly (<0.0001).
TRH and TRH-OH used as standards in the radioimmunoassays have been purchased from Sigma. This activity, like enzymatic PAMase activity described in other tissues (22) , required the presence of CuS04, ascorbate, and molecular oxygen and is therefore referred to as pancreatic PAMase in the rest of the text.
Ascorbate requirement was the same as in other tissues, but the optimal concentration of CuS04 in pancreatic preparations (close to 40 ,uM) was four and eight times higher than in the anterior (10 ,M) and neurointermediate (5 ,uM) lobe of the pituitary gland, respectively. CuS04 concentrations >50 ,uM resulted in an inhibition of this activity. In the absence of molecular oxygen in the reaction mixture, there was a 60% decrease of the pancreatic PAMase activity. The velocity of the enzymatic reaction appeared to be of the same order of magnitude in the 3-day-old rat pancreas (4 pmol/hr per ,ug of protein) and in the adult rat pituitary gland (10 and 2 pmol/hr per ,tg of protein in the anterior and neurointermediate lobe, respectively).
Ontogenetic Evolution of Pancreatic PAMase Activity. As shown in Fig. 1 [and as published by different groups (4-6) ], immunoreactive TRH concentrations in the rat pancreas reached a peak 4 days after birth and then decreased rapidly toward the minute levels found in adults. PAMase activity was already detectable in the pancreata from 19-day fetuses. The highest PAMase activity was observed in 3-day-old rats. Thereafter, PAMase activity decreased rapidly with a 50% reduction between the third and fourth day of life. Then a plateau was reached between the fifth and eighth day; Ability of Pancreatic PAMase Activity to Convert the Tetrapeptide <Glu-His-Pro-Gly into TRH. As shown in Table  1 , high levels of immunoreactive TRH were generated after incubation of <Glu-His-Pro-Gly with the mitochondrial/ secretory granule preparation, indicating that the high PAMase activity in the pancreas of 3-day-old rats may be responsible for the high rate of synthesis ofTRH at this stage. However, the levels of TRH generated under these conditions were lowerter d hat expected on the basis of the conversion rate of t PMabeled D-Tyr-Val-Gly into p25aclas beled D-Tyr-Val-NH2. Indeed, in osday-old rats, the amidation activity was lower by a factor of 7.8 when measured with <Glu-His-Pro-Gly rather than D-Tyr-Val-Gly as a substrate. (4) D-Tyr-Val-NH2 was generated from D-Tyr-Val-Gly. Results are expressed as the mean of two determinations. The difference between extreme values and the mean was <5%. The number of animals per determination is given in parentheses.
Cellular Localization of Pancreatic PAMase Activity. As shown in Table 2 , the treatment with streptozotocin induced a 50% and 55% decrease of PAMase activity in 4-and 6-day-old rats, respectively. Since streptozotocin toxicity is specific for beta cells, these data suggest that about one-half of the PAMase activity is present in these cells. Subcellular Localization of Pancreatic PAMase Activity.
After subcellular fractionation of 3-day-old rat pancreas homogenates over an isoosmotic Percoll density gradient, the distributions of PAMase activity and of TRH and TRH precursor (the putative product and substrate of pancreatic PAMase, respectively) were shown to display similar profiles, characterized by a single peak containing >80% ofthese activities (Fig. 2) . This peak corresponded to organelles of density between 1.06 and 1.08 and also contained most of insulin immunoreactivity (results not shown). DISCUSSION TRH concentrations in the pancreata from neonatal rats are very high during a short, transient period (4) (5) (6) . The physiological role of TRH in the pancreas of neonates is not understood; however, the rapid changes in TRH levels in the rat pancreas during the neonatal period make this tissue an interesting model for studying the mechanisms and regulation of TRH biosynthesis. Pancreata from adult rats that display low levels of TRH contain very low, barely detectable 15 -%.. (23) and TRH precursor (9) . TRH precursor levels are expressed as ng of TRH-OH generated after sequential enzymatic treatment with trypsin and carboxypeptidase
A.
amounts of PAMase activity (20) . Pancreata from neonatal rats contain very high PAMase activity, which peaks on the third postnatal day. The ontogenetic evolution of PAMase activity in the pancreas is parallel to that of TRH in this tissue, suggesting a direct relationship between both substances. The colocalization of TRH, its precursor, and PAMase activity in the subcellular fractions of pancreatic tissue adds further evidence for a role of PAMase activity in the biosynthesis of TRH. In addition, pancreatic PAMase activity is able to generate TRH, when incubated with <Glu-His-Pro-Gly, a tetrapeptide that has been identified as a repetitive sequence present in the TRH precursor (11) . This tetrapeptide has been utilized as a substrate to demonstrate the capacity of hypothalamic and hypophysial PAMase to generate TRH (19, 25, 26) . The reduction of PAMase activity in the pancreata of streptozotocin-injected rats has two implications. First, it suggests that, like insulin and TRH (27, 28) , part of this enzymatic activity is contained in the beta cells of the islets of Langerhans. Second, it indicates also that a significant fraction of PAMase activity is present in pancreatic tissue outside of the beta cells, in other cells of the islets of Langerhans and/or in exocrine pancreas. Indeed, peptide amidation activity has been described in exocrine tissues, including the rat exocrine pancreas (29) . PAMase activity may be directed toward proteins other than TRH precursor in the pancreas. This activity has been assumed to be involved in the amidation process of various pituitary peptides, such as a-melanocyte-stimulating hormone (a-MSH), oxytocin, and vasopressin. PAMase activity in the pancreas may have also a broad specificity and be involved in the synthesis of other peptides. The list of peptides ending with amidated residues and present in the pancreas includes vasoactive intestinal polypeptide, secretin, gastrin-releasing peptide, neuropeptide Y, pancreatic polypeptide (PP), and gastrin. Detailed information on the postnatal evolution of all of these peptides is not yet available. However, the evolution of gastrin levels in the neonate rat pancreas strikingly follows a pattern similar to that of TRH (30) . The number of PP-storing cells increases abruptly in 5-to 7-day-old rats (31) . Interestingly, the plateau of PAMase activity between the fifth and seventh day occurs during the period of maximum increase of PP cell number.
Other data from our group indicate that the ontogenetic evolution of TRH precursor in the pancreas parallels that of PAMase activity and TRH (unpublished results). Thus, it appears that the levels of a neuropeptide precursor (TRH precursor) and of an enzymatic activity (PAMase activity) involved in the posttranslational modifications of this precursor are similarly regulated in the neonate rat pancreas. The COOH-terminally amidated peptide, a-MSH is normally produced by the neurointermediate lobe ofthe pituitary gland through the processing of proopiomelanocortin by several proteolytic enzymes, acetylating enzyme, and PAM activity. It has been reported that glucocorticoids decrease proopiomelanocortin levels and PAMase activity in At-T20 cells (32) . No information is available on the effects of glucocorticoids on the activity of other enzymes involved in the processing ofproopiomelanocortin. It must be noted that At-T20 cells do not synthesize a-MSH, probably because proteolytic cleavages of proopiomelanocortin do not give rise to a suitable substrate for PAMase activity in these cells. Hence, the function of PAMase activity in At-T20 cells is not yet determined. Nevertheless, it is interesting to note that the syntheses of peptide precursors and PAMase activity are coregulated in two different tissues.
It has been shown that bovine neurointermediate pituitary contains two forms of PAMase activity that differ in apparent molecular weight (33) . Further studies are needed to characterize and purify PAMase in the pancreas. These investigations would allow the determination of the reaction mechanism of this enzyme and the development of antibodies and cDNA probes, and hence the ability to study the localization and regulation of this (these) enzyme(s).
